# Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

> **NCT00691678** · PHASE2 · COMPLETED · sponsor: **Dawn L. Hershman** · enrollment: 53 (actual)

## Conditions studied

- Breast Cancer
- Joint Pain

## Interventions

- **DRUG:** Chondroitin
- **DRUG:** Glucosamine

## Key facts

- **NCT ID:** NCT00691678
- **Lead sponsor:** Dawn L. Hershman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2012-07
- **Final completion:** 2012-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691678, "Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00691678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*